Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes
Marc S. Sabatine(Brigham and Women's Hospital), Eugene Braunwald(Mass General Brigham), Christopher P. Cannon(Brigham and Women's Hospital), James A. de Lemos(Universität Hamburg), David A. Morrow(University of California, San Francisco), Sabina A. Murphy(Brigham and Women's Hospital), Carolyn H. McCabe(Brigham and Women's Hospital), Elliott M. Antman(Brigham and Women's Hospital), C. Michael Gibson(Baim Institute for Clinical Research), Nader Rifai(Harvard University)
Cited by 740
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k